There are only 2 reasons you submit a pilot study as an abstract
1. Your true study results are not ready yet
2. Or (preaaranged with the meeting administrators) the study results are so important that you don't want them leaked to the "public" so a placeholder abstract is submitted knowing that the full results will be embargoed until say a press conference...humm
that's true ... conroy seemed not to be putting the cart before the horse yesterday ... he is a man of integrity imo ... if he wants to be a public servant ... this part of his life will be scrutinized ... if the results beat or don't beat guidance he played it well yesterday at the cc
One thing we definitely KNOW from the conference call is that the results, whatever they may be, are good enough to have established the feasibility of such a test and to justify proceeding to an FDA registration trial.
my guess is the pilot study had so-so results. to prevent an investor panic, the company had to put out this press release. which sort of means the validation study beat the accuracy hurdles otherwise why bother?